Masimo Corporation (MASI) recently unveiled MX-5 OEM circuit board, a technology platform that consumes approximately half of the power utilized by other previously available rainbow circuit boards to deliver breakthrough rainbow Pulse CO-Oximetry non-invasive measurement performance.
Following the announcement of the launch, shares of Masimo went up 0.7% to close at $21.07 till the last trading session.
Masimo circuit boards are used by Original Equipment Manufacturers (OEM) to deliver non-invasive measurements in their own medical devices and patient monitors. Until now, enabling the non-invasive measurement capabilities of rainbow Pulse CO-Oximetry required an average power of 550 milliwatts.
The low power consumption of the MX-5 circuit board varies between 250 and 320 milliwatts of power on an average, depending on the rainbow parameters being measured. This approximate 50% reduction in power usage allows integration into next-generation patient monitoring solutions that feature smaller, lighter and more portable patient monitoring devices equipped with the enhanced capabilities of non-invasive measurements.
In addition to the lower power demands compared to previous rainbow technology boards, the MX-5 can dynamically scale power consumption further depending on the type of parameters being measured to permit even longer battery run-time.
Masimo’s MX-5 OEM board offers full functionality of the rainbow technology for non-invasive measurements of total hemoglobin, oxygen content, carboxyhemoglobin, methemoglobin, and acoustic respiration rate. It also supports Measure-Through Motion and Low Perfusion oxygen saturation, pulse rate, and perfusion index measurement capabilities of Masimo SET pulse oximetry.
The introduction of Masimo’s MX-5 circuit board reflects upon the company’s relentless focus on technological improvement. It also enables OEMs to integrate rainbow's non-invasive measurements into the design and development of smaller, more portable monitoring devices for a variety of existing and emerging health care applications, ultimately leading to better patient outcomes.
Currently, Masimo carries a Zacks Rank #3 (Hold). Better-ranked medical instrument stocks include Alphatec Holdings, Inc. (ATEC), ERBA Diagnostics, Inc. (ERB) and Edwards Lifesciences Corp. (EW). Alphatec Holdings and ERBA Diagnostics sport a Zacks Rank #1 (Strong Buy) while Edwards Lifesciences carries a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment